Stocks · Health care · Pharmaceutical Preparations

Fulcrum Therapeutics, Inc.

FULC Clue Score33

United States Fiscal year ends December CIK 0001680581 Results filed 27 Apr 2026

Add to watchlist

By person

6 insiders · 14 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Ra Capital Management, L.p. entity

10% owner

—

$58.38M (3)

−$58.38M

6,053,960

7.93%

$21.31M

−40.8%

Kevin Tang

10% owner

$1.49M (6)

—

+$1.49M

7,080,945

9.28%

$24.92M

+6.3%

Robert J Gould

Director

—

$504.44K (3)

−$504.44K

454,864

0.5962%

$1.60M

−9.0%

Alan Ezekowitz

Director

—

$65.61K (1)

−$65.61K

10,927

0.0143%

$38.46K

−62.2%

Curtis Gale Oltmans

Chief Legal Officer

—

$44.60K (1)

−$44.60K

10,252

0.0134%

$36.09K

−25.2%

Greg Tourangeau

Principal Accounting Officer

—

14,062

0.0184%

$49.50K

−3.4%

Fulcrum Therapeutics, Inc.

What the insiders did Net selling

By person